-
EP2236132
European procedure
Extract from the Register of European Patents
EP About this file: EP2236132
| EP2236132 - Pharmaceutical composition for the treatment of insomnia by sublingual administration [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.05.2015 Database last updated on 09.04.2026 | Most recent event Tooltip | 29.05.2015 | No opposition filed within time limit | published on 01.07.2015 [2015/27] | Applicant(s) | For all designated states Orexo AB Box 303 751 05 Uppsala / SE | [2010/40] | Inventor(s) | 01 /
Pettersson, Anders Vinningstorp 130 44297 Kode / SE | 02 /
Nyström, Christer Bygatan 14 79535 Rättvik / SE | [2013/41] |
| Former [2010/40] | 01 /
Pettersson, Anders Orexo AB PO Box 303 75105 Uppsala / SE | ||
| 02 /
Nyström, Christer Holmvägen 22B 756 61 Uppsala / SE | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2014/30] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham, NG1 5GG / GB | ||
| Former [2013/37] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2010/40] | McNeeney, Stephen Phillip, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 10001406.7 | 24.09.1999 | [2010/40] | Priority number, date | SE19980003240 | 24.09.1998 Original published format: SE 9803240 | [2010/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2236132 | Date: | 06.10.2010 | Language: | EN | [2010/40] | Type: | B1 Patent specification | No.: | EP2236132 | Date: | 23.07.2014 | Language: | EN | [2014/30] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.08.2010 | Classification | IPC: | A61K31/19, A61K31/34, A61K31/44, A61K38/16, A61K9/16, A61K31/445 | [2010/40] | CPC: |
A61K9/006 (EP,US);
A61K9/16 (KR);
A61K31/136 (EP,US);
A61K31/19 (EP,US);
A61K31/196 (US);
A61K31/34 (EP,US);
A61K31/341 (EP,US);
A61K31/44 (EP,US);
A61K31/4439 (US);
A61K31/445 (EP,US);
A61K31/4468 (EP,US);
A61K31/4745 (EP,US);
A61K31/485 (US);
A61K31/4985 (EP,US);
A61K31/5415 (EP,US);
A61K31/5513 (EP,US);
A61K31/635 (US);
A61K36/84 (EP,US);
A61K38/2242 (EP,US);
A61K9/0056 (EP,US);
A61K9/146 (US);
A61K9/2018 (EP,US);
A61K9/2054 (EP,US);
A61K9/2866 (EP,US);
A61P11/00 (EP);
A61P25/04 (EP);
A61P25/20 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/10 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2010/40] | Title | German: | Pharmazeutische Zusammensetzung für die Behandlung von Schlafstörungen durch sublinguale Verabreichung | [2010/40] | English: | Pharmaceutical composition for the treatment of insomnia by sublingual administration | [2010/40] | French: | Composition pharmaceutique pour le traitement de l'insomnie par la voie sub-linguale | [2010/40] | Examination procedure | 25.02.2010 | Examination requested [2010/40] | 15.07.2011 | Amendment by applicant (claims and/or description) | 26.06.2012 | Despatch of a communication from the examining division (Time limit: M06) | 02.11.2012 | Reply to a communication from the examining division | 11.06.2013 | Communication of intention to grant the patent | 29.08.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.09.2013 | Communication of intention to grant the patent | 12.03.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 12.05.2014 | Fee for grant paid | 12.05.2014 | Fee for publishing/printing paid | 12.05.2014 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP05077875.2 / EP1652518 | EP99952867.2 / EP1115383 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19990952867) is 09.10.2003 | Opposition(s) | 24.04.2015 | No opposition filed within time limit [2015/27] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 12.05.2014 | Request for further processing filed | 12.05.2014 | Full payment received (date of receipt of payment) Request granted | 23.06.2014 | Decision despatched | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 14.07.2011 | Request for further processing filed | 14.07.2011 | Full payment received (date of receipt of payment) Request granted | 14.10.2011 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 14.07.2011 | Request for further processing filed | 14.07.2011 | Full payment received (date of receipt of payment) Request granted | 14.10.2011 | Decision despatched | Fees paid | Renewal fee | 25.02.2010 | Renewal fee patent year 03 | 25.02.2010 | Renewal fee patent year 04 | 25.02.2010 | Renewal fee patent year 05 | 25.02.2010 | Renewal fee patent year 06 | 25.02.2010 | Renewal fee patent year 07 | 25.02.2010 | Renewal fee patent year 08 | 25.02.2010 | Renewal fee patent year 09 | 25.02.2010 | Renewal fee patent year 10 | 25.02.2010 | Renewal fee patent year 11 | 14.09.2010 | Renewal fee patent year 12 | 30.08.2011 | Renewal fee patent year 13 | 28.09.2012 | Renewal fee patent year 14 | 30.09.2013 | Renewal fee patent year 15 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] EP0324725 (KABIVITRUM AB et al.) [X] 1-16 * columns 3,4; example 2 * | [Y] EP0144243 (RECKITT & COLMANN PROD LTD et al.) [Y] 1-16 * example 4 * | [X] WO9004962 (KABIVITRUM AB et al.) [X] 1-16 * page 1, lines 11-16 * * page 8, lines 26-28 * * page 9, lines 4-21 * * example 1 * | [Y] US4229447 (PORTER WILLIAM R et al.) [Y] 1-16 * column 2, lines 36-45; example 1 * | [YP] GASEROD O ET AL: "THE ENHANCEMENT OF THE BIOADHESIVE PROPERTIES OF CALCIUM ALGINATE GEL BEADS BY COATING WITH CHITOSAN", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 175, 1998, AMSTERDAM, NL, pages 237 - 246, XP002964881, ISSN: 0378-5173 [YP] 1-16 * the whole document * DOI: http://dx.doi.org/10.1016/S0378-5173(98)00277-4 | [Y] DUCHENE D ET AL: "Bioadhesion of solid oral dosage forms, why and how?", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 44, no. 1, July 1997 (1997-07-01), ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, pages 15 - 23, XP004256896, ISSN: 0939-6411 [Y] 1-16 * the whole document * DOI: http://dx.doi.org/10.1016/S0939-6411(97)00097-0 | [Y] WESTERBERG M ET AL: "Physicochemical aspects of drug release. XVIII. The use of a surfactant and a disintegrant for improving drug dissolution rate from ordered mixtures", S.T.P. PHARMA SCIENCES 1993 FRANCE, vol. 3, no. 2, 1993, pages 142 - 147, XP009062599, ISSN: 1157-1489 [Y] 1-16 * the whole document * | [Y] ANONYMOUS: "ATIVAN Sublingual tablets", 1985, XP002592367, Retrieved from the Internet | [A] FARRAR J T ET AL: "ORAL TRANSMUCOSAL FENTANYL CITRATE: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL FOR TREATMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS", JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. 90, no. 8, 15 April 1998 (1998-04-15), US DEPT. OF HEALTH, EDICATIONAND WELFARE, PUBLIC HEALTH, US, pages 611 - 616, XP001058154, ISSN: 0027-8874 [A] 1-16 * the whole document * DOI: http://dx.doi.org/10.1093/jnci/90.8.611 |